Institutional Ownership Anebulo Pharmaceuticals, Inc. (ANEB)
This table provides information about the institutional ownership of Anebulo Pharmaceuticals, Inc. (ANEB). We have compiled data on the 22 institutions that hold shares in the stock, with a total of 22.2 Million shares, which have been reported (via 13F filing form) to have a value of $52.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
22 Nw, LP
Seattle, WA |
Nov 14, 2025 Q3 2025 |
15,467,300
shares
|
$36.5 Million
25.71% of portfolio
|
Q4 2024
Added 188.23%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Nov 14, 2025 Q3 2025 |
3,036,325
shares
|
$7.17 Million
0.29% of portfolio
|
Q4 2024
Added 494.11%
|
|
|
Mangrove Partners
New York, NY |
Nov 14, 2025 Q3 2025 |
2,525,252
shares
|
$5.96 Million
0.77% of portfolio
|
Q4 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
399,404
shares
|
$942,593
0.0% of portfolio
|
Q3 2025
Added 0.05%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
306,540
shares
|
$723,434
0.0% of portfolio
|
Q3 2025
Added 41.95%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
174,108
shares
|
$410,894
0.0% of portfolio
|
Q3 2025
Reduced 15.37%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2025 Q3 2025 |
157,720
shares
|
$372,219
0.06% of portfolio
|
Q4 2024
Reduced 0.09%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
28,500
shares
|
$67,260
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
24,393
shares
|
$57,567
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Rangeley Capital, LLC
New Canaan, CT |
Nov 14, 2025 Q3 2025 |
20,000
shares
|
$47,200
0.04% of portfolio
|
Q3 2025
New holding
|
|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
19,153
shares
|
$45,201
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
18,836
shares
|
$44,452
0.0% of portfolio
|
Q4 2024
Reduced 0.75%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
12,768
shares
|
$30,132
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,761
shares
|
$8,875
0.0% of portfolio
|
Q2 2024
Reduced 7.11%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
2,138
shares
|
$5,045
0.0% of portfolio
|
Q3 2025
Added 26625.0%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2025 Q3 2025 |
1,750
shares
|
$4,130
0.0% of portfolio
|
Q3 2025
Reduced 46.19%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
891
shares
|
$2,102
0.0% of portfolio
|
Q3 2025
Reduced 74.43%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
399
shares
|
$941
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
220
shares
|
$519
0.0% of portfolio
|
Q3 2025
Added 139.13%
|
|
|
Fny Investment Advisers, LLC
|
Dec 15, 2025 Q3 2025 |
95
shares
|
$224
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Citigroup Inc
|
Nov 10, 2025 Q3 2025 |
6
shares
|
$14
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|
|